Biopharmas raising money in public or private financings, including: Cure Ventures, Diamond, Mosaic, OS Therapies, Psyence, Recce, Redhill, Viking.

New hires and promotions in the biopharma industry, including: Acasti, Aicuris, Arkuda, Biogen, Entrada, Flamingo, Legend, Mitsubishi Tanabe, Quantro.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Masimo.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Celularity, Davita, Greenbrook TMS, Labcorp, Lucid Diagnostics, Medtronic, Semler Scientific.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Juno Diagnostics.

Med-tech firms raising money in public or private financings, including: BBS, Bio-Techne, Mercy Bioanalytics, Wilson Wolf.

New hires and promotions in the med-tech industry, including: Deep Six AI, Emmes, Imperative Care, Wyss Center.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alexion, Alligator, Ascendis, BMS, Cabaletta, Chiesi Global Rare Diseases, Citius, Fennec, Huidagene, Hutchmed, Inmune, Kiromic, Neurobo, Novartis, Samsung Bioepis, Sandoz, Sequana Medical, Soligenix, Tango, TG, Vertex.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ablaze, Aisa, Alexion, Alimera, Aptevo, Arrowhead, Beigene, Citius, Concentra, Cyclerion, Enlivex, Evergreen, Galapagos, Genenta, GSK, Horus, JCR, Jounce, Medexus, Mitsubishi Tanabe, Novalix, Orbit, Orexo, Panbela, Pathai, Rayzebio, Redx, Regimmune, San Fu, Scorpion, and Xoma.